−19.14USD
−81.186MUSD
1.064M
About Axcella Health Inc.
Sector
Industry
CEO
William R. Hinshaw
Website
Headquarters
Cambridge
Employees (FY)
11
Founded
2008
ISIN
US05454B2043
Axcella Health, Inc. is a biotechnology company. It engages in the research and development of treatment for diseases and improves health using endogenous metabolic modulator, or EMM, and compositions. Its product pipeline includes AXA1665, for the reduction in risk of recurrent overt hepatic encephalopathy, and AXA1125, for non-alcoholic steatohepatitis. The company was founded by Noubar B. Afeyan, Geoffrey von Maltzahn, and David A. Berry on August 27, 2008 and is headquartered in Cambridge, MA.
AXLA BullishMACD cross recently and the ADX is showing a relatively strong trend around 25 with the D+ well above D-.
The two most recent candles are very bullish. The most recent making a wide ranging hammer that closed above the .38 fibonacci level and the 200 SMA. OBV is rising, confirming price action.
$AXLA is gonna fall todayPupm&Dump trading strategy idea.
$AXLA is rising too much today.
The demand for shares of the company looks lower than the supply.
This and other conditions can cause a fall in the share price today.
So I opened a short position from $4,78;
stop-loss — $5,17;
take-profit — $4,02.
Do not view th
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
